Market News
Stay updated with the latest market trends, earnings, and economic indicators.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

Should You Own More Gold? Experts Weigh In After ETF Restrictions Across Mutual Funds
Both advisors argued that the discussion should not be limited to gold. Instead, it should prompt investors to think more broadly about diversification.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.

IDFC First Bank to ICICI Bank, SBI: Nifty Bank jumps over 1% as RBI swap facility lifts bank shares
The RBI's new swap facility aims to lower hedging costs for banks on foreign borrowings, enhancing liquidity. Despite recent gains, analysts suggest caution as the Bank Nifty remains volatile within a broad trading range.
SBI, PNB, other PSU bank stocks tumble up to 21% from record highs. Time to buy or wait?
Public sector bank stocks have seen a significant drop from their recent peaks. The Reserve Bank of India has introduced measures to attract foreign investment in government securities. Experts suggest these steps are positive for the banking sector. However, caution is advised, with a focus on quality banks possessing strong fundamentals.
Sebi reviews broker net-worth norms, IPO price discovery framework
Market regulator is examining broker capital requirements, IPO auction mechanisms, mutual fund liquidity rules and corporate bond market reforms to improve efficiency
State Bank of India hands over Rs 8,813 cr dividend cheque to government for FY26
SBI presented a dividend cheque of Rs 8,813 crore for the financial year 2025-26 to Union Finance Minister Nirmala Sitharaman. This payout follows SBI's strong financial performance for FY26. The bank reported a net profit of Rs 80,032 crore and an operating profit of Rs 1,23,015 crore. SBI's overall business crossed Rs 109 trillion during the year.

Tata Mutual Fund Curbs Large Inflows Into Gold ETFs Amid Record Surge in Demand
Tata Mutual Fund offers investors two routes to gain exposure to gold ETFs.
SBI pays Rs 8,813 crore dividend to government for FY26, FM Nirmala Sitharaman receives cheque
The State Bank of India (SBI) presented a dividend cheque of Rs 8,813 crore to the government for the financial year ending March 31, 2026. This follows SBI's reported 6% year-on-year rise in net profit for the January-March quarter of FY26, reaching Rs 19,684 crore.